全トランスレチノ酸のグルタミン酸受容体発現とデンドリット脊髄密度に対する影響
Yuan-Zhong Kai1, Chun Xia2, Qing-Hong Shan3
1The School of Life Sciences, Anhui University, Hefei, Anhui, China.
Frontiers in neuroscience
|September 3, 2025
まとめ
オールトランスレチノ酸 (ATRA) は,下垂体グルタマタージック伝達を変化させ,脊髄の dendritic 密度を増加させることで,うつ病のような行動を誘発します. これはATRAが
科学分野:
- 神経科学
- 分子生物学
- 精神科
背景:
- オールトランス・レチノ酸 (ATRA) は,うつ病の病原化にますます関与しています.
- 以前の研究では ヒポカンプスの変化に焦点を当てており 視床下部の関与は不明でした
- 視床下部のメカニズムを理解することは,ATRA誘発の気分障害において極めて重要です.
研究 の 目的:
- 下垂体グルタミン酸受容体発現に対するATRAの影響を調査する.
- 下垂体における 脊髄の dendritic 密度に対する ATRA の影響を調べる.
- ATRA誘発性うつ病における下垂体可塑性の役割を明らかにする.
主な方法:
- ネズミはATRAにさらされ,うつ病のような行動が評価されました.
- レチノ酸受容体アルファ (RARα) とコルチコトロピン放出ホルモン (CRH) の低体内遺伝子発現を分析した.
- AMPA受容体のサブユニット発現と脊髄 dendritic densityは,下垂体ニューロンで定量化されました.
- 培養された下垂体ニューロンに対するATRAの効果を in vitro試験で評価した.
主要な成果:
- ATRAの曝露はネズミにうつ病のような行動を誘発した.
- 下垂体RARαとCRHの発現が上昇した.
- 異常なAMPA受容体サブユニット発現 (GluR1,GluR2,GluR4) が観察されました.
- ATRAは,特に第2次および第3次 dendritesにおいて,in vivoおよびin vitroモデルにおいて,脊髄の dendritic densityを著しく増加させた.
結論:
- ATRAは下垂体グルタマタージックシグナル伝達とシナプス構造を変化させます.
- 脊椎の dendritic 密度の増加は 神経の可塑性の変化を示唆しています.
- これらの発見は,ATRA誘発のうつ病の分子メカニズムに関する新しい洞察を提供します.
関連する概念動画
Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Transducer Mechanism: G Protein–Coupled Receptors
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
GPCRs are also called heptahelical, 7TM, or...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Antihypertensive Drugs: Action of β1 Blockers
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...


